Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT06798259
Active, not recruiting Observational

Autonomic Dysfunction in Patients With Migraine: Cardiovascular and Neurophysiology Assessment

NCT06798259 · tracked via the Priya Life Science Egypt tracker
Sponsor
Beni-Suef University
Phase
Observational
Started
2025-01-07
Last updated
2025-01-29

Condition(s) studied

Migraine Headache

Study summary

Autonomic dysfunction in patients with migraine: cardiovascular and neurophysiology assessment.

Eligibility

Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria: * 1.fulfilling ICHD-3 criteria for migraine 2. migraine for at least 3 months. Exclusion Criteria: brain imaging showing structural brain lesions. .medications that could impact autonomic function such as tricyclic antidepressants, anticholinergics, or opioids. * Patients with concomitant medical illness causing autonomic dysfunction such as: diabetes, cardiovascular, demyelinating or degenerative neurological disorders. * Contraindications for performing the tilt test * Pregnant patients.

Primary outcome measure(s)

  • Autonomic dysfunction in patients with migraine — baseline
    assessment of autonomic dysfunction using Composite autonomic system Score 31

Trial sites (1)

FacilityCityRegionStatus
Benisuef university hospital Benisuef Benisuef

More Beni-Suef University trials in Egypt

Manual Diaphragmatic Release Technique on Exercise Capacity and Sleep Quality Recruiting
ComfiJ Versus Conventional Double-J Stent for Ureteral Stent Symptoms Recruiting
A Comparative Study of EMG Biofeedback and Pharmacotherapy for the Treatment of Masticatory Muscle Hyperactivity in Bruxism Patients Starting soon
Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization Recruiting
Alveolar Cleft Reconstruction With Cortical-Shells Recruiting

Other trials for the same condition

Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06798259 on ClinicalTrials.gov ↗ ← All trials in Egypt